Post-locoregional treatment imaging of hepatocellular carcinoma

Author(s): Dr Pawan Patel, Jonathan Gabriel, Arpan Patel

Hospital: St George's Hospital, London

Reference: RAD Magazine, 48, 567, 9-10


Approximately 80% of cirrhotic patients with locoregional hepatoma cannot be managed surgically and are classified as unresectable. Treatment of hepatocellular carcinoma (HCC), however, includes a multitude of locoregional therapies that can variously be used with curative or non-curative intent. These therapies are known to increase overall survival and disease-free survival in those patients for whom surgical resection is not appropriate.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more